Syllable

company

About

Syllable uses AI to transform the way healthcare systems initiate and cultivate relationships with patients.

  • 1 - 10

Details

Last Funding Type
Series C
Last Funding Money Raised
$40M
Industries
Artificial Intelligence,Education,Health Care,Software
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Syllable is an AI powered healthcare services company that transforms the way healthcare systems initiate and cultivate relationships with patients. Long call hold times, rerouted or dropped calls and misinformation can all contribute to a frustrating patient experience and make it cumbersome to access vital care quickly. Syllable helps patients navigate their journey to health with empathy, transparency and intelligence from the moment they request care by dialing the phone or visiting a healthcare system’s website. Founded in 2016, Syllable’s solutions are in use by some of the largest and most respected healthcare providers across America.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$68M
Syllable has raised a total of $68M in funding over 2 rounds. Their latest funding was raised on Feb 7, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 7, 2022 Series C $40M 2 Detail
Jun 30, 2021 Series B $28M 1 Oak HC/FT Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Syllable is funded by 2 investors. Verily and Oak HC/FT are the most recent investors.
Investor Name Lead Investor Funding Round
Verily Series C
Oak HC/FT Series C